The use of new technologies in the detection of balanced translocations in hematologic disorders

Current Opinion in Genetics & Development
Lisa G ShafferBlake C Ballif

Abstract

The cytogenetic evaluation of hematologic disease can confirm a diagnosis, determine treatment options, and provide prognostic information to the patient. Among the potential cytogenetic aberrations that can be identified are certain balanced translocations with recurrent breakpoints that provide disease classification and define the sites of disease-causing or disease-promoting genes. In this review, we discuss the importance of balanced translocation identification, the methods traditionally used to identify balanced translocations in the cytogenetics laboratory, and the application of new methodologies such as next generation (NextGen) sequencing and array-based translocation identification through a linear amplification application. These new technologies have the potential to identify all currently known diagnostically and prognostically important rearrangements as well as novel alterations that may provide new therapeutic targets to enhance treatment of hematologic disease.

References

Apr 1, 1997·Nature Genetics·F MitelmanB Johansson
Jan 11, 2000·Nucleic Acids Research·J L HuretA Bernheim
Sep 1, 1960·Experimental Cell Research·P S MOORHEADD A HUNGERFORD
Oct 12, 2004·Leukemia Research·Victor J MahaffeyGordon W Dewald
Feb 11, 2005·Leukemia·S DemehriM W N Deininger
Nov 25, 2006·Hematology·Francesco Lo-Coco, Emanuele Ammatuna
Sep 10, 2008·Blood·Janet D Rowley
Oct 2, 2008·Blood·Alfonso Quintás-Cardama, Jorge Cortes
Dec 17, 2008·Cancer Research·David P Harper, Peter D Aplan
Mar 6, 2009·Leukemia·C MeyerR Marschalek
Jun 19, 2009·Haematologica·Robert K Slany
Sep 1, 2009·Annual Review of Genomics and Human Genetics·Janet D Rowley
Dec 3, 2010·Journal of Clinical and Experimental Hematopathology : JCEH·Hayato Tamai, Koiti Inokuchi
Dec 16, 2010·Cancer Genetics and Cytogenetics·Avery A Sandberg, Aurelia M Meloni-Ehrig
Apr 21, 2011·JAMA : the Journal of the American Medical Association·John S WelchRichard K Wilson
Jul 30, 2011·Blood·Hans SchreiberDonald A Rowley
Sep 13, 2011·The Journal of Molecular Diagnostics : JMD·Harvey A GreismanHye Son Yi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.